CIK 0001615219
- Non-accelerated filer
- Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465087339
- Phone
- +1 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 44 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-21 | Hadfield Robert General Counsel & Secretary | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2015-12-14 | Westphal Christoph H President and CEO | Purchase | +927 | $12.01 | $11K | 3,925,248 |
| 2015-12-07 | Westphal Christoph H President and CEO | Purchase | +907 | $12.02 | $11K | 3,924,321 |
| 2015-11-30 | Westphal Christoph H President and CEO | Purchase | +887 | $12.32 | $11K | 3,923,414 |
| 2015-11-23 | Westphal Christoph H President and CEO | Purchase | +971 | $11.39 | $11K | 3,922,527 |
| 2015-11-19 | KOZIN MARC D Director | Purchase | +4,500 | $11.38 | $51K | 4,500 |
| 2015-11-11 | HAHN MARINA President, Consumer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2015-11-11 | Lindemann Katharine Chief Operating Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2015-11-11 | PEREZ ROBERT J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 12 of 12 · 229 trades